Andros Medicines
Boston, US · Founded 2026 · Delaware corporation
Founders & leadership
Board
KB
Khalil BarrageBoard director
AB
Antoine BaroukyBoard director
JM
John MaraganoreBoard director
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2026
▶$3MraisedJul 2026 · 2 investors · PharmaceuticalsRule 506(b)
▶$3MraisedJul 2026 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John MaraganoreExecutive Officer, Director
- Khalil BarrageDirector
- Antoine BaroukyDirector
- Offering amount
- $5M
- Amount sold
- $3M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware, 2026
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Andros Medicines raised?
- Andros Medicines has disclosed $3M raised across 1 round.
- Where is Andros Medicines headquartered?
- Andros Medicines is headquartered in Boston, US.